Found 15 matching trials
A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma PHASE2 This study is a prospective, observational clinical study. In this study, 3...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Adebrelimab Neoadjuvant Treatment for Resectable ESCC NA This is a prospective, phase II, exploratory clinical trial.
The study aim...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study PHASE2 This is a domestic exploratory, single-arm clinical study enrolling patient...
Show More Location
The Affiliated Hospital of Putian University
Learn More & Join Trial
Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen PHASE2 To evaluate the efficacy and safety of adebrelimab combined with TP chemoth...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations PHASE2 This is a prospective, single-arm study to investigate the efficacy and saf...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma PHASE1 This is a prospective, single-arm, Phase Ib/II clinical study to evaluate t...
Show More Learn More & Join Trial
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors PHASE1 The aim of this study is to observe and evaluate the tolerability, safety, ...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC PHASE2 Esophageal cancer is a malignant tumor with high incidence rate and mortali...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC PHASE2 To evaluate the efficacy and safety adebrelimab in Combination with chemoth...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study PHASE2 Observing the efficacy and safety of 2 cycles versus 4 cycles of Adebrelima...
Show More Location
Tangdu Hospital Affiliated to the Fourth Military Medical University
Learn More & Join Trial